Lauren Charlot
Lauren Charlot has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
A. Hunt
UMASS Medical School, Eunice Kennedy Shriver Center, Waltham, MA, USA
2 shared publicationsC. Deutsch
UMASS Medical School, Eunice Kennedy Shriver Center, Waltham, MA, USA
2 shared publicationsAnne Hunt
Eunice Kennedy Shriver Center , University of Massachusetts Medical School
1 shared publicationAranya Albert
Eunice Kennedy Shriver Center , University of Massachusetts Medical School
1 shared publicationCurtis K. Deutsch
Eunice Kennedy Shriver Center , University of Massachusetts Medical School
1 shared publicationDaniel F. Connor
Department of Psychiatry , University of Connecticut Medical School
1 shared publication
Latest Publications
- 12 February 2013
- Published by Taylor & Francis in Journal of Mental Health Research in Intellectual Disabilities
- Vol. 6 (2) , 74-105
Intellectual Disabilities and Mental Health: United States–Based Research
In the United States, research directed specifically at improving our understanding of the psychiatric assessment and treatment of individuals with intellectual disabilities (ID) has grown, yet lags far behind efforts for typically developing children and adults. In the United States, a lack of a national approach to the mental health problems of people with ID has likely contributed to a lack of a clear and cohesive national research agenda for “dual diagnosis” of intellectual disabilities and mental health disorders. Despite these concerns, much has been learned and important progress has been made. This article provides an overview of the latest developments in research and social policy on behalf of persons with ID and mental health needs in the United States.
- 12 February 2013
- Published by Taylor & Francis in Journal of Mental Health Research in Intellectual Disabilities
- Vol. 6 (2) , 74-105
Intellectual Disabilities and Mental Health: United States–Based Research
In the United States, research directed specifically at improving our understanding of the psychiatric assessment and treatment of individuals with intellectual disabilities (ID) has grown, yet lags far behind efforts for typically developing children and adults. In the United States, a lack of a national approach to the mental health problems of people with ID has likely contributed to a lack of a clear and cohesive national research agenda for “dual diagnosis” of intellectual disabilities and mental health disorders. Despite these concerns, much has been learned and important progress has been made. This article provides an overview of the latest developments in research and social policy on behalf of persons with ID and mental health needs in the United States.
- 18 January 2011
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 55 (2) , 199-209
Non‐psychiatric health problems among psychiatric inpatients with intellectual disabilities
Background Physical distress resulting from medical problems has been found to cause increased behaviour problems in patients with intellectual disabilities (ID). Despite this fact, little has been documented on the medical problems of individuals with ID admitted for inpatient psychiatric care. We conducted an exploratory investigation based on a retrospective chart review of the medical problems and medications for 198 people with ID who had been admitted to a specialised inpatient psychiatric unit. Most patients were referred for admission because of aggressive, disruptive and self‐injurious behaviours. The average length of stay was 17.6 days.Methods We tallied the total number of medical problems and medications listed in the patients' discharge summaries. Because longer stays are disruptive, costly and associated with greater overall impairment, we examined the relationship between length of stay and frequency of discharge medical diagnoses. We also assessed whether or not the number of psychoactive medications correlated with the number of medical diagnoses. The effects of other demographic and diagnostic variables on rates of medical diagnoses and medications were also evaluated, including gender, age group (16–25, 26–45, 46–60, >60), level of ID (mild, moderate or severe ID) and diagnosis of an autism spectrum disorder or Down syndrome (DS).Results Inpatients with a higher number of medical diagnoses had longer lengths of stay (Spearman r = +0.32, P < 0.0001). There was a significant correlation between number of psychoactive medications and number of medical problems (Spearman r = +0.32, P < 0.0001). The most frequent medical comorbidity was constipation, reported in 60% of the inpatients (n = 118), while gastro‐esophageal reflux disease was identified in 38% (n = 75). Older inpatients had an increased number of medical problems, as might be expected, but a diagnosis of an autism spectrum disorder, gender and level of ID had no detectible effect on rates of either medical diagnoses or medications. There were only 13 inpatients with DS; in this modest sample, it was found that they had higher rates of osteoarthritis, cardiac problems, hearing loss, hypothyroidism and sleep apnoea than peers without DS, as is consistent with previous findings on overrepresented conditions in this trisomy.Conclusions In the present study, individuals with ID admitted for inpatient psychiatric care exhibited high rates of medical problems, and these were associated with duration of inpatient stay. Based on these findings, further investigation of the effects of medical problems on behaviour among individuals with ID admitted for inpatient psychiatric care is warranted.
- 18 January 2011
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 55 (2) , 199-209
Non‐psychiatric health problems among psychiatric inpatients with intellectual disabilities
Background Physical distress resulting from medical problems has been found to cause increased behaviour problems in patients with intellectual disabilities (ID). Despite this fact, little has been documented on the medical problems of individuals with ID admitted for inpatient psychiatric care. We conducted an exploratory investigation based on a retrospective chart review of the medical problems and medications for 198 people with ID who had been admitted to a specialised inpatient psychiatric unit. Most patients were referred for admission because of aggressive, disruptive and self‐injurious behaviours. The average length of stay was 17.6 days.Methods We tallied the total number of medical problems and medications listed in the patients' discharge summaries. Because longer stays are disruptive, costly and associated with greater overall impairment, we examined the relationship between length of stay and frequency of discharge medical diagnoses. We also assessed whether or not the number of psychoactive medications correlated with the number of medical diagnoses. The effects of other demographic and diagnostic variables on rates of medical diagnoses and medications were also evaluated, including gender, age group (16–25, 26–45, 46–60, >60), level of ID (mild, moderate or severe ID) and diagnosis of an autism spectrum disorder or Down syndrome (DS).Results Inpatients with a higher number of medical diagnoses had longer lengths of stay (Spearman r = +0.32, P < 0.0001). There was a significant correlation between number of psychoactive medications and number of medical problems (Spearman r = +0.32, P < 0.0001). The most frequent medical comorbidity was constipation, reported in 60% of the inpatients (n = 118), while gastro‐esophageal reflux disease was identified in 38% (n = 75). Older inpatients had an increased number of medical problems, as might be expected, but a diagnosis of an autism spectrum disorder, gender and level of ID had no detectible effect on rates of either medical diagnoses or medications. There were only 13 inpatients with DS; in this modest sample, it was found that they had higher rates of osteoarthritis, cardiac problems, hearing loss, hypothyroidism and sleep apnoea than peers without DS, as is consistent with previous findings on overrepresented conditions in this trisomy.Conclusions In the present study, individuals with ID admitted for inpatient psychiatric care exhibited high rates of medical problems, and these were associated with duration of inpatient stay. Based on these findings, further investigation of the effects of medical problems on behaviour among individuals with ID admitted for inpatient psychiatric care is warranted.
- 29 September 2008
- Published by Taylor & Francis in Journal of Mental Health Research in Intellectual Disabilities
- Vol. 1 (4) , 238-253
Mood and Anxiety Symptoms in Psychiatric Inpatients with Autism Spectrum Disorder and Depression
Recent reports suggest that individuals with autism spectrum disorders (ASD) may experience depression at a high frequency, yet few published studies address this issue, especially among adults. In the current investigation, we reviewed features of depression and comorbid traits among depressed inpatients with intellectual disabilities (ID) as a function of ASD. A retrospective chart review was performed for 53 inpatients meeting criteria for depression (13 individuals with ASD and ID and 40 matched individuals with ID but without ASD), all of whom had received a diagnosis of depression at the time of discharge from a specialty psychiatric unit for adults with ID. The depression diagnoses were based on a comprehensive clinical assessment; specific mood and anxiety symptoms were reported by informants at the time of intake using the Mood and Anxiety Semi-Structured (MASS) Interview for Patients with Intellectual Disabilities ( Charlot, Deutsch, Hunt, Fletcher, & McIlvane, 2007 Charlot, L. , Deutsch, C. , Hunt, A. , Fletcher, K. and McIlvane, W. 2007. Validation of the Mood and Anxiety Semi-Structured (MASS) Interview for Patients with Intellectual Disabilities. Journal of Intellectual Disabilities Research, 51: 821–834. [Crossref], [PubMed], [Web of Science ®] , [Google Scholar] ). Overall, few qualitative differences were detected between the 2 groups. Both depressed inpatient groups had high rates of comorbid anxiety disorders as well as externalizing behaviors. Inpatients with ASD had a total of 2 more symptoms (out of 29 possible symptom items) than their depressed peers without an ASD diagnosis (mean scores of 12.23 and 9.85, respectively). Anxiety disorders were reported in 62% of individuals with ASD and 38% of those without ASD. Antipsychotic medication was prevalent among the patients with ASD and depression. Over 80% of the inpatients with ASD and depression, compared with 49% of the non-ASD group, were treated with these medications.
- 29 September 2008
- Published by Taylor & Francis in Journal of Mental Health Research in Intellectual Disabilities
- Vol. 1 (4) , 238-253
Mood and Anxiety Symptoms in Psychiatric Inpatients with Autism Spectrum Disorder and Depression
Recent reports suggest that individuals with autism spectrum disorders (ASD) may experience depression at a high frequency, yet few published studies address this issue, especially among adults. In the current investigation, we reviewed features of depression and comorbid traits among depressed inpatients with intellectual disabilities (ID) as a function of ASD. A retrospective chart review was performed for 53 inpatients meeting criteria for depression (13 individuals with ASD and ID and 40 matched individuals with ID but without ASD), all of whom had received a diagnosis of depression at the time of discharge from a specialty psychiatric unit for adults with ID. The depression diagnoses were based on a comprehensive clinical assessment; specific mood and anxiety symptoms were reported by informants at the time of intake using the Mood and Anxiety Semi-Structured (MASS) Interview for Patients with Intellectual Disabilities ( Charlot, Deutsch, Hunt, Fletcher, & McIlvane, 2007 Charlot, L. , Deutsch, C. , Hunt, A. , Fletcher, K. and McIlvane, W. 2007. Validation of the Mood and Anxiety Semi-Structured (MASS) Interview for Patients with Intellectual Disabilities. Journal of Intellectual Disabilities Research, 51: 821–834. [Crossref], [PubMed], [Web of Science ®] , [Google Scholar] ). Overall, few qualitative differences were detected between the 2 groups. Both depressed inpatient groups had high rates of comorbid anxiety disorders as well as externalizing behaviors. Inpatients with ASD had a total of 2 more symptoms (out of 29 possible symptom items) than their depressed peers without an ASD diagnosis (mean scores of 12.23 and 9.85, respectively). Anxiety disorders were reported in 62% of individuals with ASD and 38% of those without ASD. Antipsychotic medication was prevalent among the patients with ASD and depression. Over 80% of the inpatients with ASD and depression, compared with 49% of the non-ASD group, were treated with these medications.
- 8 August 2007
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 51 (10) , 821-834
Validation of the Mood and Anxiety Semi‐structured (MASS) Interview for patients with intellectual disabilities
Background When assessing people with intellectual disabilities (ID), using the DSM‐IV‐TR can be challenging. Frequently, significant clinical data must be obtained from interviews with key informants. A new semi‐structured interview tool was developed including behavioural descriptions of each DSM‐IV‐TR symptom criterion for a number of mood and anxiety disorders. A goal was to provide mental health clinicians with an instrument easy to use in clinical practice that would increase reliable identification of diagnostically important mood and anxiety symptoms. This is especially important given the fact that many experts believe these ‘internalizing’ clinical syndromes may often be missed in this population, because of characteristic limitations in expressive language skills.Method To establish validity, the Mood and Anxiety Semi‐structured (MASS) Interview‐derived diagnoses were compared with clinical DSM‐IV diagnoses derived from an extensive inpatient evaluation and classifications based on the Hamilton Depression Rating Scale for 93 psychiatric inpatients served on a specialized unit for people with ID and major mental health disorders.Results Agreement with the MASS Interview was high yielding significant kappa coefficients ranging from 0.42 to 0.78.Conclusions The MASS Interview, a semi‐structured interview containing behavioural descriptions of DSM‐IV symptom criteria, shows promise as a potentially helpful tool in the psychiatric diagnostic evaluation of persons with ID and limited expressive language skills, in the detection of mood and anxiety disorders. The tool also yields a wide breadth of clinical information and is easy for mental health clinicians to use.
- 8 August 2007
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 51 (10) , 821-834
Validation of the Mood and Anxiety Semi‐structured (MASS) Interview for patients with intellectual disabilities
Background When assessing people with intellectual disabilities (ID), using the DSM‐IV‐TR can be challenging. Frequently, significant clinical data must be obtained from interviews with key informants. A new semi‐structured interview tool was developed including behavioural descriptions of each DSM‐IV‐TR symptom criterion for a number of mood and anxiety disorders. A goal was to provide mental health clinicians with an instrument easy to use in clinical practice that would increase reliable identification of diagnostically important mood and anxiety symptoms. This is especially important given the fact that many experts believe these ‘internalizing’ clinical syndromes may often be missed in this population, because of characteristic limitations in expressive language skills.Method To establish validity, the Mood and Anxiety Semi‐structured (MASS) Interview‐derived diagnoses were compared with clinical DSM‐IV diagnoses derived from an extensive inpatient evaluation and classifications based on the Hamilton Depression Rating Scale for 93 psychiatric inpatients served on a specialized unit for people with ID and major mental health disorders.Results Agreement with the MASS Interview was high yielding significant kappa coefficients ranging from 0.42 to 0.78.Conclusions The MASS Interview, a semi‐structured interview containing behavioural descriptions of DSM‐IV symptom criteria, shows promise as a potentially helpful tool in the psychiatric diagnostic evaluation of persons with ID and limited expressive language skills, in the detection of mood and anxiety disorders. The tool also yields a wide breadth of clinical information and is easy for mental health clinicians to use.
- 27 September 2002
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 46 (6) , 517-524
Obsessional slowness in Down's syndrome
Background: Obsessional slowness was originally described by S. Rachman in 1974. His patients had obsessive–compulsive disorder (OCD) and spent hours performing daily routines such as bathing, dressing and eating. Although some ritualistic behaviours were seen, slowness was the most prominent problem for these patients. Subsequently, a number of similar case reports emerged. In 1994, R. J. Pary described a small number of patients who had both obsessional slowness and Down's syndrome (DS). Apart from this, only one other report of slowness symptoms in people with developmental disabilities has been found in the literature, and this individual also had DS.Methods: In the present exploratory case series report, 11 individuals with DS and slowness are described based on a retrospective chart review. Descriptive data and four case vignettes are presented.Results: The 11 individuals with DS were described as spending hours engaged in usual daily routines. Several individuals had tics, hypothyroidism and periods of freezing. Although some ritualistic behaviours were described, slowness was seen to occur in the absence of these, and often without manifest anxiety.Discussion: Obsessional slowness may be a severe variant of OCD. Although it appears to occur infrequently, there may be an elevated rate in people with DS. The current report is severely limited in scope since the case descriptions were based on a retrospective review. However, because of the paucity of published information about this clinical phenomena, it was felt that the case series might serve to establish the need for further, more systematic, prospective evaluation of individuals with DS and clinically significant slowness.
- 27 September 2002
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 46 (6) , 517-524
Obsessional slowness in Down's syndrome
Background: Obsessional slowness was originally described by S. Rachman in 1974. His patients had obsessive–compulsive disorder (OCD) and spent hours performing daily routines such as bathing, dressing and eating. Although some ritualistic behaviours were seen, slowness was the most prominent problem for these patients. Subsequently, a number of similar case reports emerged. In 1994, R. J. Pary described a small number of patients who had both obsessional slowness and Down's syndrome (DS). Apart from this, only one other report of slowness symptoms in people with developmental disabilities has been found in the literature, and this individual also had DS.Methods: In the present exploratory case series report, 11 individuals with DS and slowness are described based on a retrospective chart review. Descriptive data and four case vignettes are presented.Results: The 11 individuals with DS were described as spending hours engaged in usual daily routines. Several individuals had tics, hypothyroidism and periods of freezing. Although some ritualistic behaviours were described, slowness was seen to occur in the absence of these, and often without manifest anxiety.Discussion: Obsessional slowness may be a severe variant of OCD. Although it appears to occur infrequently, there may be an elevated rate in people with DS. The current report is severely limited in scope since the case descriptions were based on a retrospective review. However, because of the paucity of published information about this clinical phenomena, it was felt that the case series might serve to establish the need for further, more systematic, prospective evaluation of individuals with DS and clinically significant slowness.